Doctors from NYU Langone Medical Center: Langone This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.


Abstract:
Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this novel infection. As a result of in vitro evidence suggesting zinc sulfate may be efficacious against COVID-19, our hospitals began using zinc sulfate as add-on therapy to hydroxychloroquine and azithromycin. We performed a retrospective observational study to compare hospital outcomes among patients who received hydroxychloroquine and azithromycin plus zinc versus hydroxychloroquine and azithromycin alone. Methods: Data was collected from electronic medical records for all patients being treated with admission dates ranging from March 2, 2020 through April 5, 2020. Initial clinical characteristics on presentation, medications given during the hospitalization, and hospital outcomes were recorded. Patients in the study were excluded if they were treated with other investigational medications. Results: The addition of zinc sulfate did not impact the length of hospitalization, duration of ventilation, or ICU duration. In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744). Conclusion: This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.

Source:
https://www.researchgate.net/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients

Popular Posts in the Last 7 Days

HHV-6 and Male infertility (from Perplexity)

Do financial markets know that HHV-8, the KS virus, might be African Swine Fever?

Perplexity on K.S. and AIDS and inflammation

What is next for Fauci?

Bulletin #116 from the Coordinating Committee of The International HHV-6 Protest and Teach-in at Harvard (November 9-11, 2015)

The argument that the increasing sophistication of genetics is pulling the rug out from under the whole concept of disease causation

More evidence linking Chronic Fatigue Syndrome to the AIDS epidemic

Popular Post in the Last 30 Days

Researchers evaluate options in case of African Swine Fever outbreaks in Iowa

A film everyone at NIH and CDC must see!

An important paper if Chronic Fatigue Syndrome is caused by African Swine Fever.

The Interview with Hillary Johnson

The CDC is hard at work.

Popular Posts from the Last Year

Ablashi discusses HHV-6, AIDS, Alzheimer's, and Chronic Fatigue Syndrome

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Why HIV should be referred to as "a red herring."

Dr. Rebecca Culshaw Smith's book is discussed on Twitter

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

All Time Most Popular Posts

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Was Judy Mikovits destroyed because her XMRV work would have ultimately shown HIV is a total fraud?

Is Chronic Fatigue Syndrome the other AIDS epidemic in the gay community?